Loor Gabriel, Brown Roland, Kelly Rosemary F, Rudser Kyle D, Shumway Sara J, Cich Irena, Holley Christopher T, Quinlan Colleen, Hertz Marshall I
University of Minnesota Department of Surgery, Minneapolis, MN, USA.
University of Minnesota School of Public Health, Minneapolis, MN, USA.
Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12889. Epub 2017 Feb 8.
The purpose of this study was to clarify the significance of recipient gender status on lung transplant outcomes in a large single-institution experience spanning three decades, we analyzed data from all lung transplants performed in our institution since 1986. Kaplan-Meier curves and Cox proportional hazard models were used to evaluate the effect of recipient characteristics on survival and BOS score ≥1-free survival. Logistic regression analysis was used to explore the association of gender with short-term graft function. About 876 lung transplants were performed between 1986 and 2016. Kaplan-Meier survival estimates at 5 years post-transplant for females vs males in the LAS era were 71% vs 58%. In the LAS era, females showed greater unadjusted BOS≥1-free survival than males (35% vs 25%, P=.02) over 5 years. Female gender was the only factor in the LAS era significantly associated with improved adjusted 5-year survival [HR 0.56 (95% CI 0.33, 0.95) P=.03]. Conversely, in the pre-LAS era female gender was not associated with improved survival. Female recipients showed significantly improved survival over 5 years compared to males in the LAS era. A prospective analysis of biologic and immunologic differences is warranted.
本研究的目的是在一个涵盖三十年的大型单机构经验中,阐明受者性别状况对肺移植结果的意义。我们分析了自1986年以来在本机构进行的所有肺移植数据。采用Kaplan-Meier曲线和Cox比例风险模型来评估受者特征对生存和无BOS评分≥1生存的影响。采用逻辑回归分析来探讨性别与短期移植功能之间的关联。1986年至2016年间共进行了约876例肺移植。在LAS时代,女性和男性移植后5年的Kaplan-Meier生存估计分别为71%和58%。在LAS时代,女性在5年期间显示出比男性更高的未调整的无BOS≥1生存(35%对25%,P = 0.02)。女性性别是LAS时代唯一与调整后的5年生存率提高显著相关的因素[风险比0.56(95%置信区间0.33,0.95),P = 0.03]。相反,在LAS时代之前,女性性别与生存率提高无关。在LAS时代,女性受者与男性相比,5年生存率显著提高。有必要对生物学和免疫学差异进行前瞻性分析。